{"id":1068000,"date":"2020-11-05T09:55:50","date_gmt":"2020-11-05T14:55:50","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/gritstone-oncology-reports-third-quarter-financial-results-and-recent-highlights\/"},"modified":"2024-08-18T11:41:48","modified_gmt":"2024-08-18T15:41:48","slug":"gritstone-oncology-reports-third-quarter-financial-results-and-recent-highlights","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/gritstone-oncology-reports-third-quarter-financial-results-and-recent-highlights.php","title":{"rendered":"Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights"},"content":{"rendered":"<p><![CDATA[EMERYVILLE, Calif., Nov.  05, 2020  (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported financial results for the third quarter ended September 30, 2020 and reviewed business highlights.]]><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/05\/2121175\/0\/en\/Gritstone-Oncology-Reports-Third-Quarter-Financial-Results-and-Recent-Highlights.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights\">Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post: Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/gritstone-oncology-reports-third-quarter-financial-results-and-recent-highlights.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068000","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068000"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068000"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068000\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}